2Molina R,Filella X,Auge JM.ProGRP:a new biomarker for small cell lung cancer[J].Clin Biochem,2004,37(7):505-511.
3Swellam M,Ragab HM,Abdalla NA,et al.Soluble cytokeratin-19 and E-selectin biomarkers:their relevance for lung cancer detection when tested independently or in combinations[J].Cancer Biomark,2008,4(1):43-54.
4Polberg K,Stepulak A,Zawislak J,et al.Squamous cell carcinoma antigen levels in patients with laryngeal cancer[J].Pol Merkur Lekarski,2005,19(111):375-376.
5Oremek GM,Sauer-Eppel H,Bruzdziak TH.Value of tumour and inflammatory markers in lung cancer[J].Anticancer Res,2007,27(4A):1911-1915.
6Tiseo M,Ardizzoni A,Cafferata MA,et al.Predictive and prognostic significance of neuron-specific enolase(NSE) in non-small cell cancer[J].Anticancer Res,2008,28(1B):507-513.
7Grunnet M, Sorensen JB. Carcinoembryonic antigen(CEA) as tumor marker in lung cancer[J]. Lung Cancer,2012,76(2) :138- 143.
8Matsuguma H, Suzuki H, Ishikawa y, et al. Prognostic value of preoperative serum tumor markers, including CEA, Cyfra21- 1, SCC, CA19-9, SCC, CA125, TPA, NSE, and SLX, in patientswith completely resected pathological stage I non-small cell lungcancer[J]. J Clin Oncol (Meeting Abstracts), 2007,25 (18 Suppl) :7681.
9Homma S, Satoh H, Kagohashi K, et al. Production of CA125 by human lung cancer cell lines[J]. Clin Exp Med,2004,4(3): 139.
10Mizuguchi S, Nishiyama N, Iwata T, et al. Clinical value of serum cytokeratin 19 fragment and sialyl-Lewis x in non-small cell lung cancer[J]. Ann Thorac Surg,2007,83(1):216-221.
